446 related articles for article (PubMed ID: 31140018)
1. Neuroprotection of Resveratrol Against Focal Cerebral Ischemia/Reperfusion Injury in Mice Through a Mechanism Targeting Gut-Brain Axis.
Dou Z; Rong X; Zhao E; Zhang L; Lv Y
Cell Mol Neurobiol; 2019 Aug; 39(6):883-898. PubMed ID: 31140018
[TBL] [Abstract][Full Text] [Related]
2. Sustained neurological recovery induced by resveratrol is associated with angioneurogenesis rather than neuroprotection after focal cerebral ischemia.
Hermann DM; Zechariah A; Kaltwasser B; Bosche B; Caglayan AB; Kilic E; Doeppner TR
Neurobiol Dis; 2015 Nov; 83():16-25. PubMed ID: 26316359
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory cytokines are involved in dihydrocapsaicin (DHC) and regional cooling infusion (RCI)-induced neuroprotection in ischemic rat.
Wu D; Zhi X; Duan Y; Zhang M; An H; Wei W; Dong K; Zhang Y; Shi J; He X; Zhang J; Wu C; Meng R; Ding Y; Ji X
Brain Res; 2019 May; 1710():173-180. PubMed ID: 30584925
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg1 provides neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through downregulation of aquaporin 4 expression.
Zhou Y; Li HQ; Lu L; Fu DL; Liu AJ; Li JH; Zheng GQ
Phytomedicine; 2014 Jun; 21(7):998-1003. PubMed ID: 24462216
[TBL] [Abstract][Full Text] [Related]
5. The changes of systemic immune responses during the neuroprotection induced by remote ischemic postconditioning against focal cerebral ischemia in mice.
Liu C; Yang J; Zhang C; Geng X; Zhao H
Neurol Res; 2019 Jan; 41(1):26-36. PubMed ID: 30281410
[No Abstract] [Full Text] [Related]
6. Systemic Proteasome Inhibition Induces Sustained Post-stroke Neurological Recovery and Neuroprotection via Mechanisms Involving Reversal of Peripheral Immunosuppression and Preservation of Blood-Brain-Barrier Integrity.
Doeppner TR; Kaltwasser B; Kuckelkorn U; Henkelein P; Bretschneider E; Kilic E; Hermann DM
Mol Neurobiol; 2016 Nov; 53(9):6332-6341. PubMed ID: 26572637
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
[TBL] [Abstract][Full Text] [Related]
8. The protective role of Tongxinluo on blood-brain barrier after ischemia-reperfusion brain injury.
Liu Y; Tang GH; Sun YH; Lin XJ; Wei C; Yang GY; Liu JR
J Ethnopharmacol; 2013 Jul; 148(2):632-9. PubMed ID: 23707212
[TBL] [Abstract][Full Text] [Related]
9. Electro-acupuncture treatment ameliorates intestinal inflammatory injury in cerebral ischemia-reperfusion rats via regulating the balance of Treg / γδ T cells.
Wang YL; Meng LL; Chen YL; OuYang L; Wu BF; Peng R; Lu SF; Liu Q; Zhang T; Li XX; Jing XY; Fu SP; Xu B
Brain Res; 2023 Mar; 1803():148233. PubMed ID: 36623758
[TBL] [Abstract][Full Text] [Related]
10. Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke.
Li P; Mao L; Liu X; Gan Y; Zheng J; Thomson AW; Gao Y; Chen J; Hu X
Stroke; 2014 Mar; 45(3):857-64. PubMed ID: 24496394
[TBL] [Abstract][Full Text] [Related]
11. [Effects of resveratrol on inflammatory process induced by focal cerebral ischemia-reperfusion in rats].
Liu YG; Wang XD; Zhang XB
Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(17):1792-5. PubMed ID: 17993005
[TBL] [Abstract][Full Text] [Related]
12. D-allose protects the blood brain barrier through PPARγ-mediated anti-inflammatory pathway in the mice model of ischemia reperfusion injury.
Huang T; Gao D; Hei Y; Zhang X; Chen X; Fei Z
Brain Res; 2016 Jul; 1642():478-486. PubMed ID: 27103568
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
Dong W; Li N; Gao D; Zhen H; Zhang X; Li F
J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362
[TBL] [Abstract][Full Text] [Related]
14. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood- brain barrier damage and brain oedema independently of infarct size.
Dénes A; Ferenczi S; Kovács KJ
J Neuroinflammation; 2011 Nov; 8():164. PubMed ID: 22114895
[TBL] [Abstract][Full Text] [Related]
15. Co-administration of resveratrol and lipoic acid, or their synthetic combination, enhances neuroprotection in a rat model of ischemia/reperfusion.
Saleh MC; Connell BJ; Rajagopal D; Khan BV; Abd-El-Aziz AS; Kucukkaya I; Saleh TM
PLoS One; 2014; 9(1):e87865. PubMed ID: 24498217
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol Pretreatment Protected against Cerebral Ischemia/Reperfusion Injury in Rats via Expansion of T Regulatory Cells.
Yang H; Zhang A; Zhang Y; Ma S; Wang C
J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):1914-21. PubMed ID: 27184615
[TBL] [Abstract][Full Text] [Related]
17. YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice.
Cao G; Ye X; Xu Y; Yin M; Chen H; Kou J; Yu B
Drug Des Devel Ther; 2016; 10():315-25. PubMed ID: 26834461
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol promoted the M2 polarization of microglia and reduced neuroinflammation after cerebral ischemia by inhibiting miR-155.
Ma S; Fan L; Li J; Zhang B; Yan Z
Int J Neurosci; 2020 Aug; 130(8):817-825. PubMed ID: 31858855
[No Abstract] [Full Text] [Related]
19. Breviscapine confers a neuroprotective efficacy against transient focal cerebral ischemia by attenuating neuronal and astrocytic autophagy in the penumbra.
Pengyue Z; Tao G; Hongyun H; Liqiang Y; Yihao D
Biomed Pharmacother; 2017 Jun; 90():69-76. PubMed ID: 28343073
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction.
He Q; Li Z; Wang Y; Hou Y; Li L; Zhao J
Int Immunopharmacol; 2017 Sep; 50():208-215. PubMed ID: 28683365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
